Previous Close | 12.28 |
Open | 12.03 |
Bid | 11.76 x 800 |
Ask | 12.49 x 900 |
Day's Range | 11.73 - 12.14 |
52 Week Range | 11.73 - 40.68 |
Volume | |
Avg. Volume | 806,983 |
Market Cap | 584.053M |
Beta (5Y Monthly) | 1.10 |
PE Ratio (TTM) | 69.18 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.24 (1.95%) |
Ex-Dividend Date | Feb 23, 2024 |
1y Target Est | N/A |
PROVO, Utah, April 03, 2024--Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release first quarter 2024 results after the market closes on Wednesday, May 8. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives.
Nu Skin Enterprises (NYSE: NUS), a global beauty and wellness leader, today introduced Nu Skin RenuSpa iO, a smart beauty and wellness device designed to promote overall wellness and body confidence through skin stimulation. RenuSpa iO is an FDA-cleared microcurrent body device and the latest innovation from the world's best-selling brand for beauty device systems for six consecutive years.*
PROVO, Utah, February 14, 2024--Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2023 results slightly above its latest guidance.